Search

everythinglearnresearchcommunity

for

Search:↓

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Birt–Hogg–Dubé syndrome is a rare genetic condition causing skin lesions, lung cysts, and a higher chance of kidney cancer.

Hirsutism in GCC countries is influenced by genetics, obesity, and lifestyle, with cultural stigma delaying treatment, highlighting the need for tailored health strategies.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

Consider NF1 in newborns with rare congenital anomalies.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Bioengineered skin models help reduce animal testing and advance research in cosmetics and skin disease.

A new mouse model effectively mimics vitiligo for research and drug testing.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

New treatments for epidermolysis bullosa show promise in improving patients' lives, but a cure is still not available.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

Forensic DNA phenotyping faces challenges like inconsistent terms and limited genetic knowledge.

Herbal formula shows promise for hair loss treatment.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

An 8-year-old Saudi boy was diagnosed with a rare genetic disorder causing hair loss, skin issues, and light sensitivity.

Standardizing and engineering organoids can improve their use in medicine and drug testing.

Organoid technology helps create mini-organs for studying diseases and testing drugs.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

The document concludes that dermal papilla cells are key for hair growth and could be used in new hair loss treatments.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

Engineered skin tissue is a promising tool for safer cosmetic testing.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.